These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1134 related articles for article (PubMed ID: 17560054)

  • 1. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and antimicrobial susceptibility of gram-negative bacteria isolated from bovine mastitis between 2003 and 2008 in Korea.
    Nam HM; Lim SK; Kang HM; Kim JM; Moon JS; Jang KC; Kim JM; Joo YS; Jung SC
    J Dairy Sci; 2009 May; 92(5):2020-6. PubMed ID: 19389959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of antimicrobials against six important species of gram-negative bacteria isolated from raw milk samples in Korea.
    Nam HM; Lim SK; Kim JM; Joo YS; Jang KC; Jung SC
    Foodborne Pathog Dis; 2010 Feb; 7(2):221-4. PubMed ID: 19895257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
    Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
    Marra MN; Wilde CG; Griffith JE; Snable JL; Scott RW
    J Immunol; 1990 Jan; 144(2):662-6. PubMed ID: 2295804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J
    J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of antimicrobial resistance in Gram-negative bacteria isolated from bovine mastitis in Egypt.
    Ahmed AM; Shimamoto T
    Microbiol Immunol; 2011 May; 55(5):318-27. PubMed ID: 21338385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein.
    Wasiluk KR; Leslie DB; Vietzen PS; Mayo KH; Dunn DL
    Surgery; 2004 Aug; 136(2):253-60. PubMed ID: 15300188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and antimicrobial resistance of clinical and subclinical mastitis pathogens in dairy cows in Rhône-Alpes, France.
    Botrel MA; Haenni M; Morignat E; Sulpice P; Madec JY; Calavas D
    Foodborne Pathog Dis; 2010 May; 7(5):479-87. PubMed ID: 19919286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing structure-activity relationships in bactericidal peptide betapep-25.
    Dings RP; Haseman JR; Mayo KH
    Biochem J; 2008 Aug; 414(1):143-50. PubMed ID: 18489259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
    Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J; Muello K; Victor M; Elsbach P
    J Immunol; 1984 Jun; 132(6):3109-15. PubMed ID: 6373924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
    Aichele D; Schnare M; Saake M; Röllinghoff M; Gessner A
    Infect Immun; 2006 Aug; 74(8):4708-14. PubMed ID: 16861658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
    Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL
    Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs.
    Lee EK; Kim YC; Nan YH; Shin SY
    Peptides; 2011 Jun; 32(6):1123-30. PubMed ID: 21497177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for use of recombinant BPI in the treatment of gram-negative bacterial infections.
    Elsbach P; Weiss J
    Infect Agents Dis; 1995 Jun; 4(2):102-9. PubMed ID: 7613727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.